Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Soluble Guanylyl Cyclase Beta-1 Subunit is part of the heterodimeric enzyme that catalyzes the conversion of GTP to cGMP, a key signaling molecule involved in vasodilation and other physiological processes. It works in conjunction with the alpha subunit and is activated by nitric oxide binding to its heme group, significantly increasing its enzymatic activity. This enzyme plays a crucial role in cardiovascular health by mediating vasodilation and inhibiting platelet aggregation.
Activation of soluble guanylyl cyclase enhances the conversion of GTP to cGMP, leading to vasodilation and other signaling effects.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Soluble Guanylyl Cyclase Beta-1 Subunit (sGCβ1 (Soluble Guanylyl Cyclase Beta-1) or GUCY1B1).